Ocular Therapeutix

(NASDAQ: OCUL)
Healthcare  |  Biotechnology
4.56 -0.3 -6.17%
Stock Price | July 19, 2019, 3:59 p.m.
0 Followers
Bid: 0.0
Ask: 0.0
Prev. Close: 4.86
52 Week Low: 2.35
52 Week High: 7.31
PE Ratio: 0.0
Dividend Yield: 0.0%

Company Summary

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, PTX-TP, and OTX-IVT. The ReSure product is commercially available.

Read more Read less

Recently Viewed Tickers

Premium Stock Watchlist 06/21/2016

3 years ago

Premium Stock Watchlist 12/18/2015

3 years ago

Premium Stock Watchlist 12/09/2015

3 years ago

Premium Stock Watchlist 12/03/2015

3 years ago

Free Insider Buying Report - 11/24/15

3 years ago

Premium Stock Watchlist 10/29/2015

3 years ago

Premium Stock Watchlist 10/28/2015

3 years ago